New insights into stage and prognosis in small cell lung cancer: An analysis of 968 cases

Journal of Thoracic Disease

Volumn 9, Issue 12, 2017, Pages 5101-5111

  Dayen, Charles ^a   Debieuvre, Didier ^b   Molinier, Olivier ^c   Raffy, Olivier ^d   Paganin, Fabrice ^e   Virally, Jérôme ^f   Larive, Sébastien ^g   Desurmont Salasc, Béatrice ^h   Perrichon, Marielle ⁱ   Martin, Francis ^j   Grivaux, Michel ^k  

^a Saint Quentin General Hospital   (France)

^b Hôpitaux Universitaires de Strasbourg   (France)

^c CENTRE HOSPITALIER DU MANS   (France)

^d Louis Pasteur Hospital   (France)

^e Hôpital Sud Réunion   (France)

^f Centre Hospitalier Robert Ballanger CHRB   (France)

^g Hopital des Chanaux   (France)

^h Centre Hospitalier Intercommunal de Frejus Saint Raphael   (France)

ⁱ Hopital Fleyriat   (France)

^j Centre Hospitalier Compiegne   (France)

^k CENTRE HOSPITALIER DE MEAUX   (France)

more..

Author keywords

Epidemiology; France; General; Hospitals; Mortality; Small cell lung cancer (SCLC); Stage

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; VINORELBINE TARTRATE;

AGED; ANTIANGIOGENIC THERAPY; ARTICLE; BODY MASS; CANCER PROGNOSIS; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; FRANCE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULARLY TARGETED THERAPY; NON SMALL CELL LUNG CANCER; PERFORMANCE STATUS; POSITRON EMISSION TOMOGRAPHY; SMALL CELL LUNG CANCER; SMOKING; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 85039788525     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2017.11.52     Document Type: Article

References (32)

1. van Meerbeeck JP, Fennell DA, De Ruysscher DK. Smallcell lung cancer. Lancet 2011;378:1741-55
2. Inoue M, Sawabata N, Okumura M. Surgical intervention for small-cell lung cancer: what is the surgical role? Gen Thorac Cardiovasc Surg 2012;60:401-5
3. National cancer Institute. Surveillance, Epidemiology, and End Results program (SEER). Available online: http://seer. cancer.gov/csr/1975_2012/browse_csr.php
4. Haddadin S, Perry MC. History of small-cell lung cancer. Clin Lung Cancer 2011;12:87-93
5. Blanchon F, Grivaux M, Collon T, et al. Epidemiologic of primary bronchial carcinoma management in the general French hospital centers. Rev Mal Respir 2002;19:727-34
6. Blanchon F, Grivaux M, Asselain B, et al. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol 2006;7:829-36
7. Grivaux M, Locher C, Bombaron P, et al. Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010. Rev Pneumol Clin 2010; 66:375-82
8. Locher C, Debieuvre D, Coëtmeur D, et al. Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies. Lung Cancer 2013;81:32-8
9. Debieuvre D, Locher C, Neidhardt AC, et al. Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians. Rev Mal Respir 2014;31:805-16
10. Hann CL, Rudin CM. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology 2008;22:1486-92
11. Levi F, Bosetti C, Fernandez E, et al. Trends in lung cancer among young European women: the rising epidemic in France and Spain. Int J Cancer 2007;121:462-5
12. INCa. The cancer situation in France in 2010. Collections rapports & syntheses. Boulogne-Billancourt; November 2010
13. Brink I, Schumacher T, Mix M, et al. Impact of [18F] FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2004;31:1614-20
14. Chin R Jr, McCain TW, Miller AA, et al. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. Lung Cancer 2002;37:1-6
15. Kut V, Spies W, Spies S, et al. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-Dglucose-positron emission tomography (FDG-PET). Am J Clin Oncol 2007;30:45-50
16. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM Stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706-14
17. Shepherd FA, Ginsberg RJ, Haddad R, et al. Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group. J Clin Oncol 1993;11:1592-7
18. Albain KS, Crowley JJ, LeBlanc M, et al. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 1990;8:1563-74
19. Shepherd FA, Crowley J, Van Houtte P, et al.; International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007;2:1067-77
20. Patel S, Macdonald OK, Suntharalingam M. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Cancer 2009;115:842-50
21. Jones CD, Cummings IG, Shipolini AR, et al. Does surgery improve prognosis in patients with smallcell lung carcinoma? Interact Cardiovasc Thorac Surg 2013;16:375-80
22. Lad T, Piantadosi S, Thomas P, et al. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 1994;106:320S-323S
23. Brock MV, Hooker CM, Syphard JE, et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. J Thorac Cardiovasc Surg 2005;129:64-72
24. Bischof M, Debus J, Herfarth K, et al. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Strahlenther Onkol 2007;183:679-84
25. Schreiber D, Rineer J, Weedon J, et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? Cancer 2010;116:1350-7
26. Stinchcombe TE, Gore EM. Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. Oncologist 2010;15:187-95
27. Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-71
28. De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006;24:1057-63
29. van Loon J, De Ruysscher D, Wanders R, et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010;77:329-36
30. Shirvani SM, Komaki R, Heymach JV, et al. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012;82:e91-7
31. Früh M, De Ruysscher D, Popat S, et al. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24:vi99-105
32. Debieuvre D, Oster JP, Riou R, et al. The new face of non-small-cell lung cancer in men: results of two French prospective epidemiological studies conducted 10 years apart. Lung cancer 2016;91:1-6